Philips Enhances Neurological Diagnosis with the Launch of IntelliSpace Portal 9.0

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the introduction of IntelliSpace Portal 9.0, the latest edition of its comprehensive, advanced visual analysis and quantification platform. Featuring a suite of multi-modality functions and expanded neurological tools, IntelliSpace Portal 9.0 helps radiologists detect, diagnose and follow-up on treatment of diseases, while using new machine learning capabilities to support the physician. The solution addresses radiologists' needs for tools to better support the growing group of patients with brain injuries and neurological disorders such as dementia, strokes, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).

In addition to enhancements in areas such as CT Brain Perfusion and MR T2 Perfusion IntelliSpace Portal 9.0 will offer Longitudinal Brain Imaging (LoBI) , an application for neuro reading to support the evaluation of neurological disorders over time so clinicians can monitor disease progression. Another feature is the inclusion of the NeuroQuant® measurement application (CorTech Labs, Inc.) which enables clinicians to quantify brain volume loss.

"As the rates of dementia and neurodegeneration rise, neuroradiologists need advanced tools to help referring physicians treat these challenging cases," said Professor Dr. Leo Wolansky, Acting Chief of Neuroradiology at University Hospitals Cleveland Medical Center in the United States. "IntelliSpace Portal 9.0 offers a comprehensive set of robust tools so neuroradiologists can quantify disease expediently."

With more than 70 applications and enhancements of many of the core applications, IntelliSpace Portal 9.0 is a single platform for visual analysis and quantification that spans clinical domains within radiology, including neurology, oncology, and cardiology. The platform offers improved advanced 3D rendering and refined STL export that enable clinicians to print 3D models with high-levels of detail and resolution, to help understand the anatomy. IntelliSpace Portal 9.0 also includes enhancements to a host of core applications from MR Cardiac Analysis to CT TAVI planning, and System enhancements.

"Radiology has a unique ability to influence and improve outcomes, and intelligent tools enable us to empower radiologists with the right information," said Yair Briman, Senior Vice President and General Manager of Healthcare IT for Philips. "With advances in machine learning, IntelliSpace Portal 9.0 will now be able to continually learn the usage patterns of users to enhance the important daily functions of a radiologist such as pre-preprocessing of images, encouraging faster and more streamlined diagnosis."

IntelliSpace Portal 9.0 offers multimodality clinical applications that can be accessed from any point of the hospital network. The solution can also integrate with typical PACS and hospital information systems to allow for information to be shared broadly, helping drive collaboration across the network. With the enterprise scalability of IntelliSpace Portal 9.0, neurologists can access the power of advanced analysis virtually anywhere across their organization while maintaining consistent applications and user preferences. Some additional highlights of Version 9.0 of the Portal include:

  • MR Cardiac Enhancements - Facilitates easy visual scoring in various examination contexts. The package enables comprehensive functional volumetric analysis. Enhancements to the package include Whole Heart STL export for 3D printing, and enhanced workflow and batch tools.
  • CT Spectral Applications - Philips IntelliSpace Portal Spectral Diagnostic suite of clinical applications has been optimized for the viewing and analysis of spectral data sets from the IQon Spectral CT scanner. You can access the application you need when and where you need, virtually anywhere in your enterprise. The tools help you gain a comprehensive overview of each patient, quantify quickly, and diagnose with confidence.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Gait Assessed with Body-Worn Sensors may…

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the...

Applications for the G4A Global Accelera…

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and...

Siemens Healthineers Fully on Track to M…

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR...

How to Build GDPR and HIPAA Compliant He…

The adoption of cloud and mobile technologies in healthcare is disrupting the services delivery models, and responsibilities and risks for involved actors. By their very nature, eHealth applications collect and...

Computers Equal Radiologists in Assessin…

Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led...

The Big Ethical Questions for Artificial…

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential...

Consultation: Transformation Health and …

The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care...

Novartis Launches FocalView App, Providi…

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data...

International Masters's in Medical Infor…

The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI)in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

Data in the EU: Commission Steps Up Effo…

The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal...

Philips Expands its Sleep & Respirat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has...

A New Way to Watch Brain Activity in Act…

It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology...